Pfizer CEO Says Science Will Prevail With Covid-19 Here to Stay
Albert Bourla talks about having the tools to manage the virus as we do the seasonal flu, the new variants, and the difference between the Trump and Biden administrations.
Bourla
Photographer: Maegan Gindi for Bloomberg Businessweek
In an interview with Bloomberg Editor-in-Chief John Micklethwait, one of the people most responsible for helping to vaccinate the world against Covid-19 discusses how his company is navigating the pandemic.
John Micklethwait: How frightened should we be about the new coronavirus variants?
Albert Bourla: We should not be frightened, but we need to be prepared. So we are focusing right now on having a very good surveillance network, so every time that the new variant comes up, we should be able to test, at least in the labs, if the vaccine is effective or not.